San Diego-based CareFusion (NYSE: [[tickerCFN]]), the medical equipment company that was spun out by Cardinal Health (NYSE:[[ticker:CAH)]] in late 2009, today named Kieran Gallahue as chairman and CEO, succeeding David Schlotterbeck, who had previously announced his retirement.
CareFusion, which posted $3.9 billion in sales last year, is a medical technology company with such established products as Alaris intravenous pumps, Pyxis automated dispensing and patient identification systems, ventilators and respiratory equipment, surgical prep products, and diagnostic products.
Gallahue, 47, was previously the president and CEO of San Diego-based ResMed (NYSE: [[ticker:RMD)]], which specializes in medical technology for treating, diagnosing, and managing sleep-related respiratory disorders. Gallahue joined ResMed in 2003 as president and COO of the Americas and was named global president and COO in September 2004. He took over as CEO from ResMed founder Peter Farrell in January, 2008.
Gallahue has nearly 20 years of strategic, operational, and corporate management experience in the health care industry. Before joining ResMed, he held positions of increasing responsibility at Nanogen, a San Diego DNA research and medical diagnostics firm, and at Instrumentation Laboratory, which specializes in diagnostic instruments for critical care and hemostatsis. He also held marketing, sales, and financial positions at The Procter & Gamble Company and General Electric.